Guardian

Guardian

By Guardian
Download on the App Store

Guardian episodes

  • Hull City roar back to Premier League. EFL playoffs special: Football Weekly
    Max Rushden is joined by Barry Glendenning, George Elek and Ali Maxwell after a weekend of EFL playoffs that saw Oli McBurnie take Hull City back to the Premier League for the first time in a decade. Help support our independent journalism at theguardian.com/footballweeklypod. Watch us on YouTube: https://www.youtube.com/@FootballWeeklyPodcast
    59 min
  • Do red-light masks really keep you looking young?
    Home red-light therapy devices have exploded in popularity as masks, body wraps and mittens promise to reduce wrinkles, redness and even acne. But do the claims stack up, and what other benefits are scientists investigating? Ian Sample hears from his co-host, Madeleine Finlay, and the consultant dermatologist Dr Jonathan Kentley. Kentley explains how the potential benefits of red light were discovered, how it is thought to interact with collagen in our skin, and what science has to say about its impact on our appearance. Help support our independent journalism at theguardian.com/sciencepod
    15 min
  • West Ham go down and the great guard of honour debate: Football Weekly
    Max Rushden is joined by Barry Glendenning, Barney Ronay, Jonathan Wilson and Jacob Steinberg to discuss the final day of the Premier League season. Help support our independent journalism at theguardian.com/footballweeklypod. Watch us on YouTube: https://www.youtube.com/@FootballWeeklyPodcast
    1 hr 1 min
  • Stateside with Kai and Carter – Why the fight over abortion in US isn’t finished
    The US supreme court has preserved nationwide access to mail-order abortion pills – for now. As Carter Sherman explains, the fight to protect this medication is far from over, as a nationwide, near-total abortion ban could be on the horizon. Carter speaks with Dr Angel Foster, co-founder of the Massachusetts Medication Abortion Access Project, who reveals how the legal battle over abortion pills has affected patients across the US – and what could happen next. Help support our independent journalism at theguardian.com/politicspod
    43 min
  • Stateside with Kai and Carter: why the fight over abortion pills is only just beginning
    The US supreme court has preserved nationwide access to mail-order abortion pills – for now. As Carter Sherman explains, the fight to protect this medication is far from over, as a nationwide, near-total abortion ban could be on the horizon. Carter speaks with Dr Angel Foster, co-founder of the Massachusetts Medication Abortion Access Project, who reveals how the legal battle over abortion pills has affected patients across the US – and what could happen next. Help support our independent journalism at theguardian.com/sciencepod
    43 min
  • Wes Streeting: ‘Andy Burnham doesn’t live rent free in my head’ – podcast
    Pippa Crerar sits down with Wes Streeting a week after his resignation from Keir Starmer’s cabinet. We find out what the former health secretary really thinks about Andy Burnham, where Labour has got it wrong and his vision for the leadership. Watch the full episode in video on YouTube here. Help support our independent journalism at theguardian.com/politicspod
    40 min
  • Can a name change transform PCOS outcomes for women?
    After more than a decade of global consultation, polycystic ovary syndrome – which affects as many as one in eight women – has been renamed. The condition is caused by high levels of androgens, which can lead to symptoms such as excess hair, weight gain and irregular periods. To understand why campaigners wanted it renamed, and what its new name – polyendocrine metabolic ovarian syndrome (PMOS) – could mean for patients, Madeleine Finlay hears from the Guardian’s science correspondent, Nicola Davis, and Rachel, a campaigner from the charity Verity. Help support our independent journalism at theguardian.com/sciencepod
    17 min

About Guardian

From the publisher's feed

Latest news, sport, business, comment, analysis and reviews from the Guardian, the world's leading liberal voice.